Investing Profile

Andrew Schwab


Founder & Managing Partner at 5AM Ventures

5amventures.comSan Francisco, California
Photo of Andrew Schwab, Managing Partner at 5am Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
5am Ventures Managing Partner
$100K - $5.0M
CompanyStageDateRound SizeTotal Raised
Novome Biotechnologies
Series BSep 2022$44M
Series AJan 2020$33M
Seed RoundMar 2018$4.5M
Co-investors: Kiersten Stead (DCVC (Data Collective)), Dan Janney (Alta Partners)
CAMP4 Therapeutics
Series BJul 2022$100M
Series AJun 2021$45M
Co-investors: Jorge Conde (Andreessen Horowitz), Shaan C. Gandhi (Northpond Ventures)
Escient Pharmaceuticals
Series BSep 2020$78M
Series AMay 2018$40M
Co-investors: JeenJoo Kang (The Column Group), Jason P. Hafler (Sanofi Ventures)
Cleave Therapeutics
Series CAug 2019$12M
Series BAug 2016$26M
Series ANov 2011$42M
Co-investors: Robert Garland (New Enterprise Associates (NEA)), Carol Gallagher (New Enterprise Associates (NEA)), Peter Thompson (OrbiMed), Kush Parmar (5am Ventures), Marc Singer (Osage University Partners), Larry Lasky (The Column Group), Alfred Scheidegger (Nextech Invest)
Post-IPO EquityMay 2015$12M
Venture RoundApr 2012$7.2M
Venture RoundApr 2010$4M
Bird Rock Bio
Series BMar 2014$15M
Series AMay 2009$13M
Series AJan 2009$25M
Series AApr 2008$8M
Co-investors: Richard Ulevitch (5am Ventures), Simeon J. George (SR One), Roel Bulthuis (INKEF Capital)
DVS Sciences
Series AJul 2011$15M
CymaBay Therapeutics
Series ENov 2009$8.6M
Series DApr 2007$32M
Co-investors: Tony Evnin (Venrock), Bali Muralidhar (Abingworth)